Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Demi Moore made a shock move into horror with new movie The Substance but as well as losing 20 pounds for the role, the ...

Demi Moore suffered some brutal battles behind-the-scenes of her new horror flick, as a health expert revealed everything you ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the U.S., more often people who are Black ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

Dr. Kwatra explains that for many patients with PN, reducing the itch directly leads to improvements in painful lesions.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Demi Moore's new film, The Substance, has been a hit with critics since it premiered at Cannes - but the Hollywood actress ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...